Trillium Asset Management, LLC Ligand Pharmaceuticals Inc Transaction History

Trillium Asset Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$80.55 - $106.05 $483,702 - $636,830	-6,005 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$89.56 - $126.72 $245,663 - $347,592	-2,743 Reduced 31.36%	6,005 $572,000
Q2 2020 Aug 06, 2020	SELL	$68.28 - $123.65 $12,563 - $22,751	-184 Reduced 2.06%	8,748 $978,000
Q1 2020 May 07, 2020	SELL	$63.37 - $107.88 $1,584 - $2,697	-25 Reduced 0.28%	8,932 $650,000
Q4 2019 Feb 10, 2020	SELL	$96.94 - $113.59 $47,888 - $56,113	-494 Reduced 5.23%	8,957 $934,000
Q3 2019 Nov 06, 2019	BUY	$86.25 - $120.16 $8,280 - $11,535	96 Added 1.03%	9,451 $941,000
Q2 2019 Aug 08, 2019	BUY	$107.38 - $129.34 $119,191 - $143,567	1,110 Added 13.46%	9,355 $1.07 Million
Q1 2019 May 06, 2019	BUY	$105.93 - $142.47 $408,783 - $549,791	3,859 Added 87.98%	8,245 $1.04 Million
Q4 2018 Feb 08, 2019	BUY	$128.36 - $272.13 $21,949 - $46,534	171 Added 4.06%	4,386 $595,000
Q3 2018 Nov 09, 2018	SELL	$211.18 - $274.49 $32,732 - $42,545	-155 Reduced 3.55%	4,215 $1.16 Million
Q2 2018 Aug 01, 2018	SELL	$150.77 - $207.98 $3,618 - $4,991	-24 Reduced 0.55%	4,370 $905,000
Q1 2018 May 09, 2018	SELL	$138.63 - $182.62 $23,289 - $30,680	-168 Reduced 3.68%	4,394 $726,000
Q4 2017 Feb 01, 2018	SELL	$128.36 - $147.04 $1,026 - $1,176	-8 Reduced 0.18%	4,562 $625,000
Q3 2017 Nov 02, 2017	BUY	$120.91 - $137.94 $552,558 - $630,385	4,570	4,570 $622,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Trillium Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Trillium Asset Management, LLC with notifications on news.